Pharm - S2B1 - General Principles 4
Terms
undefined, object
copy deck
- Define "Bioequivalence"
-
2 drugs that have both the same
-bioavailability
-rate of absorption - 2 drugs that are Bioequivalent will have these 3 things that are the same
-
1. Peak height concentrations (Cmax)
2. Peak times (Tmax)
3. Area under curves (AUC) - List the 3 equations for the Concentration at the Steady State
-
- - In Steady-state parameters, how many half-lives does it take to attain the Plateau state?
- 4-5
- In steady-state parameters, is TIME to plateau dependent or independent of dose?
- independent
- In steady-state parameters, is the LEVEL of plateau proportional or unproportional to the dose?
- proportional
- In steady-state parameters, when are there no fluctuations?
- with a continuous I.V. infusion
- What blunts fluctuations in steady state parameters?
- Slow absorption
- What are fluctuations proportional to in steady-state parameters?
- Dosage interval / half-life
- What 3 things is Plateau concentration proportional to?
-
1. Dose / dose interval
2. half-life
3. F / Cl (availability fraction / clearance) - What 2 things is Plateau concentration inversely related to?
-
1. Kel (elimination constant)
2. Vd (volume of distribution)
*High Elimination rate constant = Low Plateau Conc.
*High Vd = Low Plateau Conc. - Definition: the maximum concentration attained after a given dose
- Peak
- Definition: the minimum concentration obtained prior to giving the next dose
- Trough
- What does Maintenance Dose depend on?
- Clearance
- What is another term for Dosing rate?
- Maintenance dose
- List 3 equations for calculating the Dosing Rate
-
1. (Css . Cl) / F
2. (Css . Kel . Vd) / F
3. (.693 . Css . Vd) / Half-life - What does the Loading Dose depend on?
- Volume of Distribution
- What is the Equation for Loading dose?
-
(1.44 . Css . Vd) / F
*the higher the Vd = the higher the LD needs to be
*the lower the Availability Fraction = the higher the LD needs to be - How do you calculate the Rate of Infusion for IV infusion?
-
Ro = Css . Kel . Vd
*Rate of Infusion does determine the plasma level at the STEADY STATE
*Double the Infusion Rate = Plasma Level of the drug at the Steady State is doubled - How do you calculate the Loading Dose for IV infusion?
- LD = Css . Vd
- Why are loading doses given?
- A loading dose may be desirable if the time required to attain steady state by the administration of drug at a constant rate (four elimination half-lives) is long relative to the temporal demands of the condition being treated
- What is the equation for "Renal Disease Dose Adjustment"?
-
- - Definition: Study of the biochemical and physiological effects of drugs and mechanisms of actions
- Pharmacodynamics
- In dose-response relationships, what is the intensity of the response proportional to?
- the number of receptors occupied or the concentration of drug-receptor complexes
- What is INVERSELY related to the AFFINITY of drug for the receptor?
-
Dissociation constant (Kd)
- higher the affinity = lower the dissociation constant = less the drug will dissociate with the receptor - What shapes do Log-dose response (LDR)curves typically have?
-
S-shaped or sigmoidal - Define "Graded Responses"
- measures an increase in response in an individual as dose is increased
- Define "All-or-None (Quantal)" responses
- Number of individuals within group responding to a given dose; endpoint is set and an individual is either a responder or non-responder
- For an All-or-None response, a normal histogram is usually this shape
- Bell-shaped
- Definition: in All-or-none responses, this is the dose to which 50% of subjects respond
- Median effective dose (ED50)
- What is the Therapeutic Index?
-
the ratio betwen the toxic dose and the therapeutic dose, used as a measure of the relative safety of the drug for a particular treatment
*Large ratio = High TI - What is the equation for Therapeutic Index?
-
TI = LD50/ED50
= Lethal dose / Effective dose - T or F: the higher the Therapeutic Index, the safer the drug
-
True
- TI = LD50/ED50
- means the LD and ED are far from eachother - What is the equation for Margin of Safety?
-
LD1 / ED99 = dose to which it is lethal to 1% / dose to which it is 99% effective
*the higher the MS, the safer the drug -
Define A, B, and C as partial or full agonists -
A and B = full agonists
C = partial agonist - Definition: the propensity of a drug to bind with a given receptor and is inversely related to Kd
- Affinity
- Which has a higher affinity, a drug with a Kd of 10^-7 M for a receptor or one with a Kd of 10^-6?
- 10^-7
- Definition: comparative expression relating the dose required to produce a particular effect of given intensity relative to a standard reference
- Potency
- Which is more potent, a drug that exerts 50% of its maximal response at 10^-7 M or 10^-6 M?
- 10^-7
- Definition: Measure of how well a drug produces a response
- Efficacy
- Synonym for Efficacy
-
Intrinsic value
*max efficacy is assigned 100%
*Intrinsic value is assigned 1.0 - Definition of an Agonist
- stimulates a receptor, provoking a biological response
- Definition of a Partial Agonist
- provokes a maximal response somewhat less than a full agonist
- Describe an "Inverse Agonist"
- based on the concept that there is ongoing basal signal transduction occurring which is reduced by the inverse agonist
- Define a Competitive Antagonist
- Interaction of an Antagonist with a receptor does not result in stimulus for biological response, but will block the effect of agonist binding at same receptor site
- How does one overcome the effects of Competitive Antagonist?
- increase the dose of the agonist
- As the concentration of the antagonist increases, does the Emax (max effect) change?
- NO
- What is the Efficacy (Intrinsic activity) of a Competitive Antagonist?
- 0
- What will be the effect of a fixed dose of a Competitive Antagonist in a dose-response curve
-
cause a parallel shift for an agonist to the right - With Noncompetitive Antagonists, can the effect be completely overcome by increasing the agonist concentration?
- No
- What is decreased in the presence of Noncompetitive Antagonists?
- number of functional receptors
- What happens to Emax as the concentration of noncompetitive antagonists increases?
-
decreases because of fewer functional receptors available - What happens to the Dose-response curve with the presence of Noncompetitive Antagonists?
-
nonparallel, downward shift for the agonist to the right - Give 2 examples of when partial agonists act as inhibitors to a full agonist
-
1. Acebutolol is a partial agonist at the B1-adrenoreceptor
2. Selective Estrogen receptor Modulators
- Tamoxifen
- Clomifene
- Raloxifene
*As the partial agonist displaces the full agonist from the receptor, the response is reduced - the partial agonist is acting as an ANTAGONIST - Define Potentiation
- the effect of 2 drugs is greater than predicted from individual effects
- Give 2 examples of Potentiation
-
1. Physostigmine (an AChEI) potentiates the response to ACh
2. Cocaine (uptake I blocker) potentiates the effects of NE and Epi - What effect does Potentiation have on the Dose-response curve?
- shifts the agonist to the left
- Time it takes for steroids to cause a response
- Hours
- Time it takes for Insulin and Growth Factors to cause a response
- Minutes
- Time it takes for IL-2 and Cytokines to cause a response
- Minutes
- Time it takes for Nicotine to cause a response
- Milliseconds
- Time it takes for Epinephrine to cause a response
- Seconds
- Nicotinic/ACh receptors are this kind of receptor
-
Ionotropic --> Sodium channel - GABA--Benzodiazepine receptors are this kind of receptor
-
Ionotropic -> Chloride channel
-Hyperpolarization
- Inhibitory - Glutamate/AMPA receptors are this kind of receptor
-
Sodium channel
-Depolarization
-Excitatory - Glutamate/NMDA receptors are this kind of receptor
-
Ionotropic = Calcium channel
-Depolarization
-Toxicity
-Excitotoxicity - What do G proteins bind to and what do they couple with?
-
Bind to GTP
Couple with "7-TM receptors" or "Serpentine receptors" - In G protein-coupled receptors, agonists promote the release of what?
- GDP which allows for the attachment of GTP to nucleotide-binding site
- In G-protein couple receptors, when GTP is bound what is the G protein capable of?
- regulating an enzyme or ion channel
- In G Protein-Coupled receptors, how is the signal terminated?
-
hydrolysis of GTP to GDP
*slow hydrolysis of GTP allows signal to persist long after the ligand has dissociated from the receptor - What does Gs stimulate?
- Adenylyl Cyclase
- What does Gi do?
- inhibits Adenylyl Cyclase and opens K+ channels
- What does Gq do?
- stimulates phospholipase C
- What does Go do?
- closes Ca+ channel
- Explain the Adenylyl Cyclase system
-
Gs
- agonist binds receptor, couples the G-protein
GTP binds causing alpha subunit to dissociate with Beta/gamma
- alpha/GTP stimulate Adenylyl Cyclase which converts ATP to cAMP
- cAMP activates PKA
Gi = inhibits AC - List 7 stimulatory agonists for the Adenylyl Cyclase system
-
1. ACTH
2. Beta-agonists (isoproterenol)
3. Glucagon
4. FSH
5. PGE2
6. Thyrotropin
7. Dopamine D1 agonists - List 3 inhibitory agonists of the Adenylyl Cyclase system
-
1. Alpha-2 agonists = Clonidine
2. Muscarinic M2 agonists
3. Dopamine D2, D3, and D4 agonists
**MAD 2's** - Explain the model of desensitization
-
-Beta arrestin kinase phosphorylates the internal domain of the receptor when agonist binds
-When it's P'ed, beta arrestin binds and blocks coupling to Gs protein - Explain the Polyphosphoinositide Signaling system
-
1. agonist binds to receptor and activates Gq protein
2. Gq activates Phospholipase C
3. PLC cleaves PIP2 into DAG and IP3
-DAG activates PKC
-IP3 releases Ca+ -> Calmodulin-Ca+ - List 5 receptors that activate the Polyphosphoinositide signaling system
-
1. Muscarinic receptors M1 and M3
2. alpha-1 adrenoceptors
3. Vasopressin receptors (V1)
4. Angiotensin receptors (AT1)
5. Serotonin receptors (5-HT2) - What do muscarinic receptors bind?
- ACh and muscarine
- What do Alpha-1 adrenoceptors bind?
-
Norepinephrine
Phenylephrine
*PIP2 signaling system - What do Growth Factors signal through?
- Protein Tyrosine Kinase Signaling
- Examples of agonists that signal through Tyrosine Kinase receptors
-
1. PDGF
2. Insulin
3. Epidermal Growth Factor
**Insulin and Growth Factors - Explain the Receptor Tyrosine Kinase signaling system
-
1. agonist binds
2. semi-distant receptors dimerize and autophosphorylate
3. Phosphorylation of downstream substrates - What do Cytokines signal through?
-
Receptor Tyrosine Kinases linked to the JAK/STAT pathway -> dimerized STAT goes to nucleus - List 6 ligand responsive Transcrtiption Factors (Nuclear Receptors)
-
1. Glucocorticoids
2. Mineralcorticoids
3. Sex steroid hormones
4. Vitamin D
5. Thyroid hormone
6. Retinoid acid - Explain the mechanism of Glucorticoid signaling
-
1. Steroid binds to Ligand-binding domain
2. Regulator protein is released
3. Tsc-activating domain and DNA-binding domain are exposed
4. Modification of gene expression - Describe 2 ways in which Glucocorticoids are anti-inflammatory
-
1. induce synthesis of Lipocortin, an inhibitor of Phospholipase A2 (cleaves off Arachidonic acid)
2. decrease the up-regulation of COX-2 driven cytokines - Where is Nitric Oxide formed?
- Endothelial cells
- What is NO's mode of action?
- it diffuses through plasma membrane of Smooth Muscle cells activating Guanylyl Cyclase, converting GTP to cGMP
- What does NO activate?
- Guanylyl cyclase
- What does cGMP activate?
- Protein kinase G -> vasodilation
- Where is iNOS found?
- Professional killer cells
- What is the substrate for NO?
- Arginine
- How can NO be toxic?
- it reacts with Superoxide, forming the toxin Peroxynitrite